back to US directory
us clinical guidance

Older adults with multimorbidity: priorities and coordinated decisions

AGS priority-, trajectory- and burden-aware decisions when multiple disease guidelines and treatments conflict.

JurisdictionUnited States
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceUnited States healthcare professionals
This is an iatroX educational summary of named United States sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Use the named authority, current FDA labeling, applicable state law, payer rules and local protocol where relevant.

Scope of this summary

Primarily older adults living with multiple chronic conditions, functional limitations or complex treatment burden. The approach also helps younger people with high complexity. It complements鈥攏ot automatically overrides鈥攃ondition-specific emergency care, disease-modifying treatment, rehabilitation, preventive care and palliative support.
sources for this section:AGS MCC

The Bottom Line

  • Identify and communicate the person鈥檚 health priorities and likely health trajectory before adding more disease-specific interventions; priorities can include function, symptom relief, longevity, independence, cognition, caregiver sustainability and reduced treatment burden.
  • For each proposed treatment, estimate likely benefit, harm, time to benefit, workload and interaction with other conditions and medicines, acknowledging that single-disease trials often underrepresent multimorbidity.
  • Stop, start or continue care according to the person鈥檚 priorities, net benefit and feasibility rather than maximizing every disease target simultaneously.
  • Align decisions among primary care, specialists, pharmacy, rehabilitation, home services, caregivers and the patient so that one clinician鈥檚 change does not silently conflict with another plan.
  • Revisit priorities after hospitalization, new disability, diagnosis, bereavement or a change in prognosis; a preference-sensitive plan is a continuing process, not a one-time advance-directive form.
sources for this section:AGS MCC

Practical clinical workflow

1
Prepare a reconciled problem, medicine and clinician list and assess cognition, mood, function, frailty, sensory needs, social support, access, caregiver burden and the practical work of treatment.
2
Ask what matters most and what is most difficult now, then translate the answer into two or three measurable priorities such as walking to the bathroom safely or avoiding burdensome hospital visits.
3
Review treatments against those priorities, estimating time to benefit and cumulative adverse effects; identify duplication, prescribing cascades, incompatible targets and monitoring that no longer changes care.
4
Agree on changes one step at a time with explicit monitoring and restart criteria, assigning one coordinating clinician and documenting which recommendation was modified and why.
5
Create a portable care plan covering priorities, decision maker, emergency preferences, key medicines, monitoring and named follow-up, and confirm that patient and caregivers can enact it.
sources for this section:AGS MCC

Safety boundaries and escalation

  • Person-centered simplification is not abandonment: untreated pain, depression, reversible functional loss, unsafe medication withdrawal and remediable social barriers still require active care.
  • Do not infer limited prognosis from age or disability alone; use disease trajectory, frailty and the person鈥檚 values and correct reversible contributors.
  • Deprescribe slowly when rebound, withdrawal or disease recurrence is possible and coordinate changes to insulin, steroids, antiseizure drugs, anticoagulants, opioids or psychotropics.
  • Assess decision-making capacity for the specific choice and include the legally appropriate surrogate while continuing to seek the patient鈥檚 preferences and assent.
sources for this section:AGS MCC

Localization

The 2019 AGS action framework is the central US source and is older but remains directly relevant; there is no new universal federal multimorbidity drug algorithm. Payer networks and state surrogate law vary, while the priority and coordination principles remain clinical rather than entitlement claims.
sources for this section:AGS MCC

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. American Geriatrics SocietyDecision Making for Older Adults With Multiple Chronic Conditions: Executive Summary for the American Geriatrics Society Guiding Principles on the Care of Older Adults With MultimorbidityDOI 10.1111/jgs.15809 路 published 2019-01-21 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the US question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.